Aller au contenu principal
Accès ouvert déclaré 2026 article

Minocycline attenuates panicogenic responses in a CO2-induced panic attack model: a translational approach

2Citations signalées, ce qui n’est pas une note de qualité
6Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : us, br. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

There is a connection between neuroinflammation and panic attacks (PA), as microglia-driven pro-inflammatory responses help detect homeostatic disturbances like CO₂ inhalation. This model has become widely used in research since CO₂ exposure can trigger PA in humans and panic-related behavior in mice. Minocycline inhibits microglia activation, serving as a promising tool to attenuate CO2-induced PA. The locus coeruleus (LC) is a CO₂/pH-sensitive region, and disruptions in its activity are linked to psychiatric conditions such as panic disorder (PD). We investigated the involvement of microglia in the respiratory and behavioral responses induced by CO2 in mice and the effect of minocycline and clonazepam treatment. We also assessed in mice whether LC microglia are activated after hypercapnia using IBA-1 immunohistochemistry. Translationally, PD patients were treated with minocycline and clonazepam and examined for their CO2-responsiveness. LC microglia were activated 6 h after exposure to 20% CO2 in mice. This panicogenic stimulus also induced hyperventilation as well as active panic-related escape responses, characterized by jumps and running episodes. Minocycline and clonazepam decreased escape expression during the CO2 challenge, but only the former drug reduced hyperventilatory responses. None of the drugs changed IL levels in LC. In humans, minocycline reduced the severity of CO2-induced panic attacks and also modulated the immune response by lowering IL-2sRα and increasing IL-10 levels. Exposure to hypercapnia activates microglia in the LC of mice. Treatment with minocycline, similar to the clinically effective panicolytic clonazepam, attenuates CO2-induced panic-like responses in both mice and humans. These results support the potential of minocycline as a therapeutic strategy for PD.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Minocycline attenuates panicogenic responses in a CO2-induced panic attack model: a translational approach
Date Crossref
03/02/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersVagus Nerve Stimulation Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.